The QualityStocks Daily Tuesday, October 15th, 2024

Today's Top 3 Investment Newsletters

MarketClub Analysis(DRUG) $38.4900 +1,445.78%

QualityStocks(DBGI) $0.2300 +43.93%

InvestorBrandNetwork(RENB) $0.7075 +28.40%

The QualityStocks Daily Stock List

Digital Brands Group (DBGI)

QualityStocks, StockEarnings, BUYINS.NET, Schaeffer's, The Online Investor and InvestorPlace reported earlier on Digital Brands Group (DBGI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Digital Brands Group Inc. (NASDAQ: DBGI) is engaged in the provision of apparel under different brands on wholesale and direct-to-consumer basis.

The firm has its headquarters in Austin, Texas and was incorporated in 2012. Prior to its name change, the firm was known as Denim L.A. Inc. It operates as part of the retail and whole-discretionary industry, under the consumer discretionary sector, in the retail-discretionary sub-industry and serves consumers in the U.S.

The company operates through the Bailey 44 and DSTLD segments. It brings like-minded direct-to-consumer names under a single portfolio to share data, infrastructure and operational resources in an attempt to reduce redundant fixed costs that are expensive to maintain and difficult to establish. The elimination of administrative responsibilities for their brands allows innovation and creativity to be stimulated and enables brands to be committed to the product and customer experience.

The enterprise provides luxury men’s suiting under the ACE Studios brand and denims under the DSTLD brand. It is also involved in designing, manufacturing and selling women’s apparel, which includes rompers, jackets, sets, bottoms, jumpsuits, tops and dresses, under the Bailey 44 brand. It sells its products directly to the end consumer via its websites, as well as via its own showrooms, select department stores and wholesale channels in specialty stores.

The company recently announced that it would be expanding its e-commerce ecosystem by launching some brands on Amazon. This move adds another customer acquisition channel to the company’s marketing strategy and also increases brand awareness, which may boost the company’s revenues as well as funnel investments into the firm.

Digital Brands Group (DBGI), closed Tuesday's trading session at $0.23, up 43.9299%, on 100,120,131 volume. The average volume for the last 3 months is 61,170 and the stock's 52-week low/high is $0.145/$12.80.

Corsa Coal (CRSXF)

We reported earlier on Corsa Coal (CRSXF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Corsa Coal Corp (OTCQX: CRSXF) (CVE: CSO) is a coal mining firm that is focused on mining, processing and selling metallurgical coal and exploring, acquiring and developing coal resource properties.

The firm has its headquarters in Friedes, Pennsylvania and was incorporated in 2007, on June 14th. It operates as part of the coking coal industry, under the basic materials sector. The firm serves consumers around the globe.

The company operates through the Northern Appalachia Division (NAPP) and Corporate segments. The NAPP segment includes metallurgical coal operations along the Northern Appalachia coal belt while the Corporate segment supports and manages the firm's mining investments. NAPP is a distinct operating segment based on its metallurgical coal operations and location in the U.S. along the Northern Appalachia coal belt. The company's corporate office provides support and manages the mining investments.

The enterprise’s core business is supplying metallurgical coal to domestic and international steel and coke producers. It has the operational capacity at its mines to produce over 1.6 million tons of coal annually, with processing capacity at its two operating plants in excess of 4.0 million. The enterprise also operates preparation plant facilities in Somerset County.

The company recently announced its latest financial results, with its CEO noting that they remained focused on improving the company’s profitability and surface mine production as well as supporting additional spot market sales. This will bring in additional revenues into the company and bolster its overall growth.

Corsa Coal (CRSXF), closed Tuesday's trading session at $0.2, up 27.7955%, on 515,463 volume. The average volume for the last 3 months is 13.614M and the stock's 52-week low/high is $0.1138/$0.5525.

Gritstone Bio (GRTS)

MarketClub Analysis, MarketBeat, StreetInsider, QualityStocks, BUYINS.NET, TradersPro, StockMarketWatch, Prism MarketView and InvestorsUnderground reported earlier on Gritstone Bio (GRTS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gritstone Bio Inc. (NASDAQ: GRTS) (FRA: 2JQ) is a clinical-stage biotechnology firm that is focused on the development of immunotherapies against infectious illnesses and a range of cancers.

The firm has its headquarters in Emeryville, California and was incorporated in August 2015 by Jean-Charles Soria, Naiyer Rizvi, Graham Lord, Mark Cobbold, Timothy Chan and Andrew Allen. Prior to its name change in May 2021, the firm was known as Gristone Oncology Inc. It operates as part of the scientific research and development services industry, under the healthcare sector. The firm has three companies in its corporate family and serves consumers in the United States.

The company is party to a license agreement with Genevant Sciences GmbH. It is also party to a strategic collaboration agreement with Bluebird Bio Inc.; and a collaboration agreement with Gilead Sciences Inc. It markets its products in the U.S.

The enterprise’s products include an immunotherapy candidate dubbed Slate, developed to treat common solid tumors which include pancreatic cancer, colorectal cancer, metastatic non-small cell lung cancer and shared neoantigen-positive tumors. It also develops a neoantigen-based immunotherapy known as Granite, to treat solid tumors comprising colorectal cancer, bladder and micro-satellite stable cancer, gastroesophageal cancer and metastatic non-small cell lung cancer. This is in addition to developing a therapeutic vaccine candidate to protect against SARS-CoV-2 variants; and another to treat and cure HIV infection.

The company is focused on pursuing additional viral pathogens on its vaccine platform and demonstrating the value it brings to patients and stakeholders, which will positively influence the company’s investments as well as its growth.

Gritstone Bio (GRTS), closed Tuesday's trading session at $0.0686, up 27.037%, on 355,097,093 volume. The average volume for the last 3 months is 2.465M and the stock's 52-week low/high is $0.0492/$3.17.

Salarius Pharmaceuticals (SLRX)

QualityStocks, StockMarketWatch, Stocks That Move, MarketBeat, StocksEarning, Premium Stock Alerts, Money Wealth Matters and 360 Wall Street reported earlier on Salarius Pharmaceuticals (SLRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) (FRA: FP11) is a clinical stage biotechnology firm that is engaged in the development of cancer treatments that are epigenetic-based. Epigenetic refers to the regulatory system that influences gene expression.

Salarius Pharmaceuticals Inc. operates in the biotechnology industry, under the healthcare sector and is based in Houston, Texas. The firm, which was known as Flex Pharma Inc. before changing its name has been granted Product Development Award funding that totals $18.7 million by the Cancer Prevention and Research Institute of Texas in addition to other funding by the National Pediatric Cancer Foundation for the advancement of the Ewing sarcoma clinical program. Salarius Pharmaceuticals Inc. serves consumers and patients in the U.S. and was established in 2014.

Salarius Pharmaceuticals is party to strategic partnerships with the Cancer Prevention and Research Institute of Texas for various activities that entail product development; HLB Life Sciences for the development, manufacture, production and sale of the SP-2577 candidate in South Korea and the University of Utah Research Foundation for the license to patent rights that protect SP-2577 and associated compounds.

Salarius Pharmaceuticals Inc.’s product pipeline includes its lead candidate; seclidemstat, which is undergoing a phase 1/2 clinical trial for relapsed or refractory Ewing sarcoma. The candidate, which is also known as SP-2577, is also undergoing phase 1/2 clinical trials that evaluate its efficacy in treating advanced solid tumors, including ovarian, breast and prostate cancers.

As of 2020, the firm’s SP-2577 candidate had been awarded Rare Pediatric Disease Designation, Orphan Drug Designation and Fast Track Designation by the FDA. Seclidemstat employs a new approach to treat/improve Ewing sarcoma, which will not only benefit patients by addressing a previously unmet medical need but also extend the firm’s reach in the market, which will be good for its growth and investment opportunities.

Salarius Pharmaceuticals (SLRX), closed Tuesday's trading session at $1.52, up 17.8295%, on 8,131,001 volume. The average volume for the last 3 months is 1.127M and the stock's 52-week low/high is $1.26/$7.44.

Phunware (PHUN)

MarketClub Analysis, QualityStocks, StockMarketWatch, StocksEarning, StockEarnings, Schaeffer's, TradersPro, InvestorPlace, 360 Wall Street, Zacks, The Online Investor, MarketBeat, stockstotrade, TaglichBrothers, Premium Stock Alerts, InvestorsUnderground and BUYINS.NET reported earlier on Phunware (PHUN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Phunware Inc. (NASDAQ: PHUN) (FRA: 2RJ) is focused on the development of an MaaS (Multiscreen-as-a-Service) integrated enterprise platform for mobile that offers companies the data, solutions and products needed to monetize, manage and engage their audiences and mobile application portfolios on a worldwide scale.

Phunware Inc. is based in Austin, Texas and was established in 2009 by Luan Dang and Alan S. Knitowski. The firm is party to a partnership agreement with GAIN Innovation for the Texas government’s contract bids.

Phunware Inc. is part of the information technology services industry and helps highly respected brands across the globe create category-defining mobile experiences, with over a billion active devices using its platform every month.

Phunware Inc.’s product portfolio is made of enterprise mobile software which includes crypto networking, messaging and notifications, alerts, business analytics and intelligence, marketing automation, location-based services, as well as content management. The firm’s software development kits include analytics and loyalty, advertising, messaging, content management and mobile engagement. Phunware Inc. also provides audience monetization which is inclusive of one-time and recurring transactional media purchases using insertion orders, audience engagement, user acquisition application discovery and application transactions for mobile audience building. This is in addition to providing virtual and physical beacons and low and high density Wi-Fi.

Phunware Inc. recently announced its partnership with Vizzia which will provide a digital front door solution to healthcare organizations on mobile. This solution will offer visitors, patients and staff a more integrated and cohesive healthcare experience which will increase efficiency and in turn, output.

Phunware (PHUN), closed Tuesday's trading session at $5.39, up 14.6809%, on 43,764,122 volume. The average volume for the last 3 months is 17.602M and the stock's 52-week low/high is $2.85/$24.495.

SunHydrogen (HYSR)

QualityStocks, Investor News Source, OTCPicks, Beacon Equity Research, InvestorPlace, Stock Preacher, StockHideout, PennyTrader Publisher, InvestorSoup, MicroStockProfit, Penny Stocks Finder, Wallstreetlivechat, InvestorIntel, Stock Roach, TheLightningPicks, SmallCapStockPlays, OTCReporter, Investors Online Bell, Top Stock Picks, MarketClub Analysis, Hotstocked, PennyStockRumors.net, Wise Alerts, Penny Stock Finder, FeedBlitz, HotPennyInvest.com, HotOTCChina.com, Crazy Carl, CrushTheStreet.com, HotOTCBuzz.com, Greenbackers, HotOTCPicks.com, JumpingPennyStocks.com, LightningStockPicks, Nebula Stocks, AimHighProfits, OTCPennyPicks.com, Penny Stock Craze, Pumps and Dumps, Real Pennies, SmartPennyInvest.com, Stockpalooza, TheMicrocapNews, TopPennyStockMovers and OTCNewsAlerts.com reported earlier on SunHydrogen (HYSR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sunhydrogen Inc. (OTC: HYSR) is focused on generation and marketing of renewable energy and is engaged in the provision of renewable energy services.

The company is based in Santa Barbara, California and incorporated in 2009, on February 18th. It serves consumers in the state of California. Prior to its name change, the firm was known as Hypersolar Inc.

SunHydrogen caters to metal processing, ammonia production, refineries and other sectors and produces economical renewable hydrogen using sunlight. It has developed a nanoparticle system that’s solar-powered and imitates photosynthesis to separate hydrogen from water. It plans to get this system’s technology to be licensed, allowing it to be used in producing renewable hydrogen and electricity for fuel cells. It generates energy from sunlight.

Its technology, the HyperSolar H2Generator, is used to develop a submersible hydrogen production particle which splits H2O molecules under the sun. Every particle is a complete hydrogen generator and contains a high voltage solar cell that’s bonded to chemical catalysts via an encapsulation coating. It is also developing a modular system that will allow for the daily production and storage of hydrogen that can be used at any time in the manufacture of fertilizer, oil and gas refining, the generation of electricity and any other hydrogen applications.

SunHydrogen (HYSR), closed Tuesday's trading session at $0.0258, up 11.2069%, on 24,374,307 volume. The average volume for the last 3 months is 115,742 and the stock's 52-week low/high is $0.01/$0.0409.

Can Fite Biopharma (CANF)

RedChip, StockMarketWatch, Streetwise Reports, BUYINS.NET, INO.com Market Report, QualityStocks, MarketBeat, MarketClub Analysis, OTCBB Journal, Stock Analyzer, First Penny Picks, StocksImpossible, StreetInsider, StockEarnings, Broad Street, PennyStockProphet, TradersPro, Jason Bond, StockOodles, InvestorPlace, CRWEFinance, Marketbeat.com, InvestorsUnderground, Buzz Stocks, HotOTC, CRWEPicks, CRWEWallStreet, DrStockPick, Investing Futures, Red Chip, Weekly Newsletter, WealthMakers, Top Stock Picks, The Street, The Stock Dork, Street Insider, PennyOmega, StockHotTips, OTC Journal, Profitable Trader Authority, PennyToBuck, Zacks, PennyStockScholar, BestOtc, Penny Pick Finders, OTCtipReporter and StockOnion reported earlier on Can Fite Biopharma (CANF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Can Fite Biopharma Ltd. (NYSE American: CANF) (FRA: CF5B) (TLV: CANF) is a clinical-stage biopharmaceutical firm that is engaged in developing small molecule therapeutic products used to treat erectile dysfunction and inflammatory ailments as well as liver disease and cancer.

The firm has its headquarters in Petach-Tikva, Israel and was incorporated in 1994, on September 11th by Ilan Cohn and Pnina Fishman. Prior to its name change in January 2001, the firm was known as Can-Fite Technologies Ltd.

The company is party to a collaboration agreement with Univo Pharmaceuticals which entails the identification and co-development of formulations of marijuana components for the treatment of metabolic, autoimmune and inflammatory diseases, as well as cancer. It also has a collaboration agreement with CMS Medical which entails the development, manufacture and commercialization of its Namodenoson and Piclidenoson formulations.

The enterprise’s candidates include CF602, which is in preclinical trial for erectile dysfunction treatment; and, Namodenoson (CF102), which is in a phase 2 trial for treating non-alcoholic steatohepatitis and has concluded phase 2 clinical trials evaluating its effectiveness in treating hepatocellular carcinoma. It also develops Piclidenoson (CF101), which is undergoing phase 2 trials for the treatment of the coronavirus and phase 3 clinical trials for psoriasis treatment. The enterprise is also engaged in the development of predictive biomarker blood test kits for A3AR.

Can Fite Biopharma (CANF), closed Tuesday's trading session at $2.75, up 9.127%, on 301,283 volume. The average volume for the last 3 months is 15,588 and the stock's 52-week low/high is $1.81/$4.69.

Freddie Mac (FMCKL)

QualityStocks, Real Pennies and MarketClub Analysis reported earlier on Freddie Mac (FMCKL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Freddie Mac operates in the secondary mortgage market in the U.S. It buys residential mortgage loans originated by lenders, and also invests in mortgage loans and mortgage-related securities. Freddie Mac supports the housing market and the nation’s renters, homebuyers and homeowners throughout the entire nation and in all economic cycles. The Company is headquartered in McLean, Virginia and was chartered by Congress in 1970.

Freddie Mac operates by way of three business lines. These comprise Single-Family, Multifamily, and Capital Markets. The Company’s Single-Family business supports responsible, sustainable homeownership. Freddie Mac works with lenders of all sizes - national, regional, and community lenders and credit unions - to purchase conventional, conforming mortgage loans for one- to four-unit homes (including condominiums and manufactured homes) up to a certain dollar amount set by the Company’s regulator.

Freddie Mac Multifamily (working with a network of specialized vendors) provides funding for loans on properties ranging from five units to hundreds of units across manifold buildings. Moreover, the Company’s Capital Markets business promotes the mortgage market’s liquidity. It makes funding more available to borrowers through buying mortgage-related securities guaranteed by Freddie Mac and other financial institutions as investments and managing its portfolio.

Because it operates in the U.S. secondary mortgage market, Freddie Mac doesn’t lend directly to borrowers. The Company purchases loans that meet its standards from approved lenders. With the money that lenders receive in return, they can make loans to other qualified borrowers. In securitizing pools of mortgages and selling the securities to investors, Freddie Mac shifts a major portion of the credit risk associated with the loans it owns to private investors – away from taxpayers.

Freddie Mac (FMCKL), closed Tuesday's trading session at $3.73, even for the day, on 50,000 volume. The average volume for the last 3 months is 5.789M and the stock's 52-week low/high is $1.60/$4.60.

Tevogen Bio (TVGN)

Premium Stock Alerts and 360 Wall Street reported earlier on Tevogen Bio (TVGN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tevogen Bio Holdings Inc. (NASDAQ: TVGN) (NASDAQ: TVGNW) (FRA: G28) is a clinical-stage specialty immunotherapy firm focused on the development of off-the-shelf precision T cell therapies to help treat various types of cancer, infectious illnesses, and neurological disorders.

The firm has its headquarters in Warren, New Jersey and was incorporated in 2020. It operates as part of the biotechnology industry, under the healthcare sector. The firm mainly serves consumers in the United States.

The company harnesses CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations.

Tevogen Bio’s pipeline comprises of TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 601 for treating multiple sclerosis; and TVGN 489, which has concluded Phase 1 clinical trials for the treatment and prevention of chronic lingering symptoms of Long COVID, as well as elderly and infirm acute COVID-19 patients, COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 960 for the treatment of mouth and throat cancer, and TVGN 920 for treating cervical cancer.

The firm is pursuing a commercialization strategy with a focus on its ExacTcell™ technology platform, which leverages precision T cell therapies to address supportive care for cancer patients. It remains committed to maximizing returns on investments from this tech and better meeting the unmet needs of cancer patients.

Tevogen Bio (TVGN), closed Tuesday's trading session at $1.37, up 25.6881%, on 60,892,707 volume. The average volume for the last 3 months is 25.549M and the stock's 52-week low/high is $0.2556/$21.09.

Alphabet Inc. (GOOGL)

The Street, InvestorPlace, Kiplinger Today, Zacks, The Online Investor, Schaeffer's, Daily Trade Alert, Investopedia, Trades Of The Day, Market Intelligence Center Alert, Money Morning, Early Bird, MarketBeat, MarketClub Analysis, StreetInsider, Uncommon Wisdom, StreetAuthority Daily, Top Pros' Top Picks, Wealth Insider Alert, Daily Profit, StrategicTechInvestor, Wyatt Investment Research, The Street Report, Wall Street Daily, The Wealth Report, Money and Markets, TopStockAnalysts, CustomerService, Louis Navellier, AllPennyStocks, MarketWatch, StocksEarning, All about trends, Investing Daily, Daily Wealth, TipRanks, ProfitableTrading, INO.com Market Report, Stansberry Research, Investors Alley, CNBC Breaking News, Marketbeat.com, INO Market Report, QualityStocks, MarketTamer, MarketArmor.com, Market Intelligence Center, Darwin Investing Network, Trading Tips, Power Profit Trades, InsiderTrades, InvestorGuide, Stock Up Featured, Barchart, Options Elite, InvestorIntel, DividendStocks, Cabot Wealth, Total Wealth, Money Wealth Matters, GorillaTrades, SmallCapNetwork, Daily Dividends, TheOptionSpecialist, StockEarnings, The Night Owl, Dynamic Wealth Report, FreeRealTime, Jon Markman’s Pivotal Point, The Daily Market Alert, Insider Wealth Alert, WStreet Market Commentary, Investiv, Investor Guide, Eagle Financial Publications, Trader Prep, The Weekly Options Trader, InvestorsObserver Team, Investing Signal, Investing Futures, Short Term Wealth, SmallCap Network, Trading Concepts, Trade of the Week, Investing Lab, 24/7 Trader, Market Authority, Chaikin PowerFeed, StockMarketWatch, The Motley Fool, Average Joe Options, Smartmoneytrading, Jim Cramer, Contrarian Outlook, Investment House, Shah's Insights & Indictments, TradingPub, Wealth Daily, StockReport, Equities.com, The Wall Street Transcript, BUYINS.NET, Schaeffer’s, CNBC, Stock Barometer, RedChip, Financials Trends, Investment U, TrendAdvisor, Profit Confidential, Traders For Cash Flow, Investing Breakout, Inside Investing Daily, The Stock Dork, Top Pros Top Picks, Mind Over Markets, Earnings360 Newsletter, Pennystockmania, The Trading Report, Tradespoon, TradeSmith Daily, Lance Ippolito, ChartAdvisor, Energy and Capital, Chart Experts, Energy & Resources Digest, empirefinancialresearch, BillionDollarClub, Beat The Street, bullseyeoptiontrading, Candle Stick Forum, Earnings360, 360 Wall Street, Day Trade Alert, Dividend Opportunities, Economic News Room, StreetAuthority Financial, Rockwell Trading, Roundtable Roundup, SECFilings.com News, SmallCapVoice, Smart Investing Today, Smart Money Press, SmartTrading, Microcapmillionaires, Street Insider, PoliticsAndMyPortfolio.com, Summa Money, SwingTradeOnline, SystemTrading, Technology Profits Daily, Tim Bohen, Tim Sykes, wyatt research newsletter, Stock Gumshoe, Liberty Through Wealth, Greenbackers, HotStockProfits and iDigital Market reported earlier on Alphabet Inc. (GOOGL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alphabet (NASDAQ: GOOGL, GOOG) is a global technology leader known for its search engine, advertising services and various technology products. Recently, through Google, it has taken a significant step by partnering with Kairos Power, a startup focused on nuclear energy innovation. This collaboration is part of Google’s strategy to invest in sustainable energy technologies, as highlighted by CNBC’s Pippa Stevens.

The partnership with Kairos Power could influence the future of energy solutions, aligning with Google’s broader goals. Despite a slight increase of 0.35% in its stock price, reaching approximately $165.54, Google’s market capitalization remains strong at $2.05 trillion. This reflects investor confidence in Google’s strategic moves towards sustainable energy.

Today, GOOGL’s stock has fluctuated between $164.91 and $167.68, indicating market interest in the company’s recent developments. Over the past year, the stock has seen a high of $191.75 and a low of $120.21, showcasing its volatility. However, the current trading volume of 8.88 million shares suggests active investor engagement.

Google’s investment in nuclear energy through Kairos Power is a testament to its commitment to cutting-edge technologies. This move could potentially reshape the energy landscape, offering sustainable solutions. As Google continues to explore innovative energy options, its stock performance remains a focal point for investors.

To view the company’s latest earnings release, visit https://ibn.fm/1vFFk

About Alphabet Inc.

Alphabet is a collection of companies, the largest of which is Google. Larry Page and Sergey Brin founded Google in September 1998 and the company is headquartered in Mountain View, California. Billions of people use its wide range of popular products and platforms each day, like Search, Ads, Chrome, Cloud, YouTube and Android. For more information, visit the company’s website at www.ABC.xyz.

Alphabet Inc. (GOOGL), closed Tuesday's trading session at $165.46, up 0.3031038%, on 20,247,195 volume. The average volume for the last 3 months is 504,856 and the stock's 52-week low/high is $120.2057/$191.75.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, PsychedelicNewsWire, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, Prism MarketView, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Psilocybin is a psychedelic compound found in hundreds of species of hallucinogenic mushrooms. When ingested, the body converts the compound into psilocin, which is known to act on serotonin 2A receptors in the brain.

Numerous studies have shown that psilocybin can alter an individual’s cognition, mood and perception when consumed. Research has also found that the psychedelic may cause profound changes to an individual’s sense of space, self and time.

Now new research has looked into how this psychedelic affects activity in the brain and, particularly, its influence on individual neurons. For their research, the investigators studied mice that had been genetically modified, which allowed them to visualize neural activity via imaging techniques. Each mouse was trained to run on a treadmill in a fixed position, where they navigated various auditory, visual and tactile cues.

The treadmill used had been designed to imitate a virtual environment, with every mouse receiving a reward after lap completion. This system allowed investigators to analyze and record neural activity in the retro splenial cortex as each mouse performed the task. This region is important for spatial navigation and orientation.

Once this was done, the investigators carried out imaging sessions to monitor brain activity, which began by recording baseline neural activity in every mouse and administering a saline or psilocybin solution.

The investigators then compared neural activity before and after drug administration, observing that psilocybin had a huge effect on neurons in the retro splenial cortex. In their report, the researchers explained that following drug administration, neuron specificity to certain locations decreased significantly. This highlighted a reduction in the brain’s ability to encrypt spatial information.

This, they theorized, could explain why individuals under this psychedelic’s influence may experience a disrupted sense of space. Additionally, the scientists observed that psilocybin decreased coordination between neurons, which suggests that the psychedelic distorted normal patterns of communication in this particular cortex.

The investigators also pretreated some mice with ketanserin, which blocks serotonin 2A receptors. Their objective was to observe if this would modify the impact of psilocybin.

In their report, the researchers explained that changes observed in neural activity as mentioned above were prevented. This hints at these receptors interfering with the effects psilocybin has on the brain. The investigators are now focused on exploring how psilocybin affects other regions of the brain, particularly those that play a role in decision-making and motivation.

The study’s findings were reported in the “European Journal of Neuroscience.

Many more entities, such as Compass Pathways PLC (NASDAQ: CMPS), are looking to leverage the different mechanisms of action of hallucinogens in order to develop therapeutics from these substances. As more becomes known about psychedelics, many of these medicines could become legally available around the country.

Compass Pathways PLC (CMPS), closed Tuesday's trading session at $5.94, off by 2.9412%, on 398,915 volume. The average volume for the last 3 months is 23.392M and the stock's 52-week low/high is $5.01/$12.75.

Tilray Brands Inc. (TLRY)

Schaeffer's, QualityStocks, InvestorPlace, StockEarnings, StocksEarning, The Street, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Zacks, BUYINS.NET, Investopedia, CannabisNewsWire, CFN Media Group, CNBC Breaking News, Daily Profit, The Street Report, Early Bird, StreetAuthority Daily, INO Market Report, FreeRealTime, Trading Concepts, InvestmentHouse, Inside Trading, Top Pros' Top Picks, Trading For Keeps, Prism MarketView, The Rich Investor, Tip.us, AllPennyStocks, Investment House, InsiderTrades, Earnings360, Investors Alley, Eagle Financial Publications, Premium Stock Alerts, wyatt research newsletter, Wealth Daily, VectorVest, TradersPledge, TheTradingReport, The Night Owl, StrategicTechInvestor, MarketClub, Rick Saddler, InvestorsObserver Team, Outsider Club, Money Morning, 360 Wall Street, Marketbeat.com, Louis Navellier, Jim Cramer, Jason Bond, InvestorsUnderground and Stock Up Featured reported earlier on Tilray Brands Inc. (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

According to a recent examination of the existing data, teenagers who use marijuana typically do poorly academically. The JAMA Pediatrics study analyzed information from 63 different studies involving nearly 440,000 adolescents.

The findings revealed that marijuana use during teenage years is likely associated with lower academic performance, decreased chances of finishing high school, less likelihood of enrolling in college or university, and a higher likelihood of dropping out of school and being frequently absent.

One significant point the researchers noted was that marijuana use among teens is widespread, with about 22% of high school students in the United States using cannabis at least once in the previous month. Another concern is that today’s marijuana is much stronger than it used to be, with THC levels increasing from 4% in 1995 to 14% in 2019.

The study also highlighted long-term effects, stating that heavy marijuana use during adolescence could lead to lasting changes in the brain’s structure. These changes might interfere with memory, cognitive function and attention span, all of which are critical to academic success.

To investigate the potential academic consequences, the team analyzed data from numerous studies that looked at cannabis use, school performance and even employment among young people. While not all the data was equally reliable, the researchers identified evidence — classified as “moderate certainty” — linking marijuana use with several negative outcomes. Specifically, they found that teens who used marijuana had:

  • 39% higher chances of earning lower grades
  • 50% lower odds of obtaining a high school certificate
  • 28% less likelihood of attending university
  • 31% decreased chance of earning a post-secondary degree
  • more than twice as likely to drop out of high school
  • more than twice as likely to miss school often

While the research team also found some evidence, though weaker, suggesting marijuana use could be tied to unemployment, the risks generally increased the more frequently a teen used the drug. Starting at an early age (before or around 16) also seemed to worsen the academic impact.

Although the findings suggest a strong link between marijuana use and poor school outcomes, the researchers acknowledged that they couldn’t definitively prove marijuana is the direct cause. For instance, teens struggling with other substance-use problems or mental-health concerns might be more likely to use marijuana and face challenges in school. However, the researchers adjusted their results to account for such factors.

One thing is clear: As marijuana becomes more accepted and decriminalized in various parts of the world, its use among teenagers is on the rise. U.S. national data suggests that more than three million teens aged between 12 and 17 years of age had used marijuana in the past year — more than any other illegal drug.

Given these trends, the researchers emphasized the urgent need for effective programs to prevent early marijuana use and protect youth from the potential negative consequences.

The age-verification activities that licensed companies such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) implement contribute to restricting access to marijuana by minors, but much more needs to be done by all stakeholders to keep marijuana away from teens.

Tilray Brands Inc. (TLRY), closed Tuesday's trading session at $1.57, off by 1.2579%, on 19,160,184 volume. The average volume for the last 3 months is 254,296 and the stock's 52-week low/high is $1.45/$2.97.

The QualityStocks Company Corner

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Annovis Bio Inc. (NYSE: ANVS).

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on developing therapies for neurodegenerative disorders such as Alzheimer's disease ("AD") and Parkinson's disease ("PD"), announced today that the U.S. Food and Drug Administration ("FDA") has granted clearance to proceed with pivotal Phase 3 studies for buntanetap in early-stage Alzheimer's patients. This decision follows a successful End-of-Phase 2 meeting held on Oct. 10, 2024, where Annovis and the FDA aligned on the next steps for advancing buntanetap toward New Drug Application ("NDA") submissions.

The Phase 3 program will consist of two trials: a 6-month study aimed at confirming buntanetap's symptomatic benefits and an 18-month study to explore potential disease-modifying effects. The company plans to initiate the first trial in Q1 2025, with the possibility of submitting an NDA based on the completion of the 6-month study.

"We are grateful for the FDA's support in advancing our Phase 3 studies as planned," said Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio. "This clearance marks an important step forward as we work to bring buntanetap to patients in need. Our team is preparing to launch the study early next year, and we will provide ongoing updates as we progress towards our goals."

In the company's previous Phase 2/3 study, buntanetap demonstrated significant cognitive improvements in early Alzheimer's patients, while maintaining a strong safety profile. These positive results informed the Phase 3 trial design, positioning the company to further validate buntanetap's efficacy and safety in a larger patient population.

To view the full press release, visit https://ibn.fm/LWBDL

Annovis Bio Inc. Overview

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as AD and PD. Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach addresses both the cognitive decline in AD and the motor dysfunction in PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly known as Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a 3.3 point improvement compared to 0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating buntanetap’s mechanism of action.

Similarly, in the recently completed Phase III study of buntanetap in patients with early PD, buntanetap significantly improved disease-related daily non-motor and motor functions in Parkinson’s patients who had a diagnosis over 3 years as well as improved cognition in all PD patients. It further underscores buntanetap’s potential as a transformative therapy.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050​ (Alzheimer’s Association)​​ (Republican Policy Committee)​. Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease​ (SingleCare)​.

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050​​. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Recent Phase III data in Parkinson’s Disease patients demonstrates significant improvements in motor and cognitive functions.
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

  • Maria L. Maccecchini, Ph.D. – Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.
  • Cheng Fang, Ph.D. – Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.
  • Michael Christie, Ph.D. – VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.
  • Melissa Gaines – Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.
Recent Achievements

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Investment Considerations
  • Unique Market Position: Annovis Bio is uniquely positioned as the only company developing a drug for both AD and PD that inhibits multiple neurotoxic proteins simultaneously.
  • Strong Clinical Results: Buntanetap’s Phase II/III data shows significant cognitive improvement in early AD patients, and the recent Phase III data in PD patients further validates its broad therapeutic potential.
  • Strategic Growth Plans: With recent successful trial results, Annovis Bio is poised for future growth, supported by strong patent protections and upcoming clinical trials.
  • Significant Market Need: As the prevalence of neurodegenerative diseases continues to rise, the demand for effective treatments like buntanetap remains critical.

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Annovis Bio Inc. (NYSE: ANVS), closed Tuesday's trading session at $7.98, up 6.2583%, on 1,494,353 volume. The average volume for the last 3 months is 97,235 and the stock's 52-week low/high is $4.53/$22.49.

Recent News

HealthLynked Corp. (OTCQB: HLYK)

The QualityStocks Daily Newsletter would like to spotlightFathom HealthLynked Corp. (OTCQB: HLYK) .

HealthLynked (OTCQB: HLYK), a leader in connecting patients, doctors and healthcare data, has filed a patent with the United States Patent and Trademark Office ("USPTO"). According to the announcement, the nonprovisional patent covers ARi, an innovative artificial intelligence ("AI")-powered personal healthcare assistant and is designed to provide long-term protection for Ari and the company. HealthLynked noted that last year it filed a provisional patent following the release of Generative Pretrained Transformers ("GPT") and Large Language Models ("LLMs") from OpenAI.

"At HealthLynked, we are committed to empowering patients to take control of their health," said HealthLynked CEO Dr. Michael Dent in the press release. "ARi is an exciting leap forward in this mission. By integrating AI with patient medical records, we can deliver more accurate healthcare guidance tailored to the individual, significantly improving health outcomes. This is a game-changer in healthcare delivery."

To view the full press release, visit https://ibn.fm/qZjSL

HealthLynked Corp. (OTCQB: HLYK) is at the forefront of a transformative movement in healthcare, utilizing its extensive collection of health data to improve care for all. With a commitment to leveraging its advanced technology platforms, HealthLynked employs a sophisticated, cloud-based network that serves as a comprehensive repository for personal health data. This system not only simplifies the management and archiving of medical records but also enables the application of AI to deliver personalized healthcare insights. Through deep analysis of this data, HealthLynked’s AI capabilities help identify the root causes of diseases, tailor healthcare solutions to individual needs, and accelerate medical discoveries.

HealthLynked Corp. App

In addition to these capabilities, HealthLynked provides a user-friendly platform for booking healthcare appointments, similar to how OpenTable operates for restaurant reservations. This feature allows patients to conveniently book appointments with healthcare providers across the country, including options for telemedicine consultations, enhancing accessibility and efficiency in healthcare service delivery.

Strategically headquartered in Naples, Florida, HealthLynked operates through three primary divisions: Health Services, Digital Healthcare, and Medical Distribution. Each division supports the company’s mission to revolutionize patient care and health management. Positioned as a potential leader in healthcare AI, HealthLynked is dedicated to shaping the future of the industry over the next 20 years, driving significant advancements in healthcare accessibility and effectiveness through innovation and technology.

HealthLynked Corp. Reach

Strategic Initiatives and Operational Highlights

The company’s commitment to enhancing global health is evident in its dual goals: transforming healthcare through advanced technology and creating a patient-centric network that accelerates medical discoveries and the development of disease cures.

HealthLynked’s intellectual property portfolio is robust and strategically developed to enhance healthcare delivery and management. In March 2023, HealthLynked was granted a patent for a groundbreaking healthcare-specific wireless access point, known as the “Patient Access Hub.” This technology significantly improves the efficiency of healthcare practices by enabling real-time monitoring of patient flow within facilities. It intelligently determines patients waiting in exam rooms and calculates wait times, alongside other critical practice metrics. This system not only enhances patient experience by reducing unnecessary wait times but also optimizes resource allocation within healthcare settings.

Additionally, in October 2023, HealthLynked filed a patent application for its advanced AI program, ARI (Augmented Real-time Interface). ARI acts as a virtual doctor for patients, capable of performing medical intake, booking appointments, and providing personalized medical recommendations based on a patient’s medical history. By integrating these tasks, ARI streamlines the healthcare process, reducing the administrative burden on healthcare providers and ensuring that patients receive timely and tailored healthcare advice. This AI-driven interface enhances the accessibility and personalization of healthcare, embodying HealthLynked’s commitment to leveraging technology for better health outcomes. The company recently launched HealthLynked 3.2.0, an advanced version of its application, incorporating telemedicine, AI-driven personal healthcare guidance, and remote patient monitoring – setting a new standard in healthcare technology.

Market Position and Future Outlook

According to Facts and Figures Research, a research and consulting firm, the global market for patient-centric healthcare applications is projected to reach $41.6 billion by 2030, growing at a CAGR of 18.77% from 2022. HealthLynked’s offerings align perfectly with this expansive market opportunity, especially with increasing demands for digital health solutions and data management in healthcare.

HealthLynked’s strategic direction, spearheaded by its seasoned management team, is designed to leverage these market dynamics, enhancing patient engagement and healthcare efficiency on a global scale.

Management Team

Michael T. Dent, M.D., Founder, CEO, and Chairman, brings extensive experience from his foundational role at NeoGenomics and leadership in various healthcare and technology sector companies.

David Rosal, CFO, with previous senior roles at Teradata and McDonald’s Corporation, brings a wealth of expertise in financial and business integration strategies essential for growth and operational efficiency.

Chris Hall, CTO, with a strong background in global technology development from his time at Siemens and several patents to his name, is instrumental in driving the innovation and technological advancement at HealthLynked.

Bill Crupi, Operations Manager, has a proven track record in streamlining operations and enhancing productivity across multiple sectors within the healthcare industry. His expertise is crucial in maintaining the operational excellence that HealthLynked is known for.

Michael Paisan, Director of Investor Relations, leverages his extensive experience in finance and communications to enhance HealthLynked’s relationships with investors and stakeholders, ensuring transparent and effective communication of the company’s value and growth strategy.

Gagan Babber, Manager of Software Development, oversees the HealthLynked development teams based in the U.S. and India. With a robust background in engineering and software development, he plays a critical role in guiding the technological direction of HealthLynked’s products. His expertise in developing scalable, innovative software solutions is essential for driving the company’s technical initiatives forward and ensuring that HealthLynked stays at the forefront of digital healthcare technology.

HealthLynked Corp. (OTCQB: HLYK), closed Tuesday's trading session at $0.042, up 24.9256%, on 62,088 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $22.49/$.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Years after hemp was legalized with the passage of the 2018 Farm Bill, state and federal authorities are struggling to regulate its products. Following the passage of the bill, Congress failed to implement a regulatory framework for hemp products, leading to the creation of an industry where intoxicating products derived from hemp, including edibles and beverages, could be sold to essentially anyone, including minors. Data from Whitney Economics' National Cannabinoid Report shows that in 2023, the hemp-derived cannabinoid market's value was an estimated $28.4 billion. This move by the state came only weeks after California Governor Gavin Newsom announced the ban, focused on protecting minors from the effects of intoxicating hemp products. Companies such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) hope the federal authorities come up with regulations that can form a framework from which different states can take a leaf. This will bring a measure of uniformity to the laws regulating hemp products around the country.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Tuesday's trading session at $0.024, up 6.6667%, on 14,234 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

One exciting aspect of Web3 is its potential to enhance online security. In a world that is facing data breaches and cyberattacks daily, Web3 offers a new approach that is not just cutting-edge but fundamentally different from the norm. While the centralized structure of today's internet makes it vulnerable, Web3 brings a decentralized system that significantly boosts resilience to cyber threats. Have you ever heard of a DDoS attack? This occurs when hackers flood a server with so many requests that the system crashes, leaving websites and services unable to be used. An example of this occurred in 2010 when PayPal, Visa and MasterCard were knocked offline. So, what's the problem? Centralized systems! They are easy targets for these attacks. At its core, Web3 takes the internet from fragile and vulnerable to secure and resilient. By eliminating single points of failure, Web3 dramatically reduces the risks of DDoS attacks, data breaches and content tampering. It's not just an upgrade; it's a whole new way of thinking about security in the digital world. With Web3, we're doing more than just surfing the web — we're surfing it safely. For companies that have already embraced Web3, such as Horizon Fintex, the benefits of enhanced online security are passed on to the customers they work with, to the benefit of all parties involved.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

GolfLync Inc.

The QualityStocks Daily Newsletter would like to spotlight GolfLync Inc.

GolfLync, an innovative platform aimed at revolutionizing the golf experience, today announced that it has re-engaged IBN, a multifaceted financial news and publishing firm for private and public entities. IBN will leverage its extensive investor-focused distribution network, which includes 5,000+ key syndication outletsvarious newsletterssocial media channels, and wire services via InvestorWire, as well as blogs and other outreach tools, to support GolfLync's corporate communication strategies and boost awareness and visibility as the company continues its expansion.

According to the announcement, GolfLync has achieved key milestones in recent months. The company secured $3.5 million in initial funding during Q2 2024. Additionally, its flagship app, often referred to as the "Tinder for Golf" because it connects golfers by matching them with compatible players based on skill level and preference, has surpassed 150,000 app downloads across the App Store and Google Play with minimal marketing. This represents growth of over 3,000% in less than a year. The company projects that its immediate short-term market potential will exceed 10 million users.

To view the full article, visit https://ibn.fm/Iqgfh

GolfLync Inc. matches golfers looking for a game through the company’s smartphone app, GolfLync. The company bills GolfLync as “the social network for golfers,” matching golf games and players similar to the way a dating app matches those looking for romance.

The app allows like-minded golfers to connect for a game simply by logging in. GolfLync helps golfers who are looking to grow their golf network find other players with similar interests and on course preferences. Whether you have recently moved to a new area and are looking for new golfing buddies, travel frequently and would like to play a round of golf while on the road, or just want to meet new golfers in your area, GolfLync is your answer. Spouses who enjoy golfing together can find other golfing couples to tee it up with. For a regular group that finds itself unexpectedly down a player, GolfLync can help find that last-minute addition to complete the foursome.

The company is based in Scottsdale, Arizona.

GolfLync App

GolfLync was created for golfers of all skill levels and preferences to connect with compatible players of similar skill. Golfers can find a tee time through GolfLync, join existing tee times and create new leagues. The app allows golfers to meet fellow players before committing to spend four hours on the course with them. GolfLync allows users to find new golf friends based on their preferences, such as walking or riding a cart, listening to music, friendly wagering, imbibing a favorite beverage at the 19th Hole and more. GolfLync is available for both Android and iOS as a free download.

Download on Apple App Store   Get it on Google Play

Market Opportunity

According to a report by Statista, a leading provider of market and consumer data, in 2022, the number of people participating in golf in the United States reached 25.6 million, with 15.5 million additional players participating in off-course activities like driving ranges. In 2020, over 502 million rounds of golf were played in the U.S. alone. The game, traditionally dominated by male players, is changing, with increased interest from women golfers driven by social media influencers around the game.

Lumen Sports puts the total number of golf courses in the U.S. at more than 16,700. According to Lumen, about 75% of those are public courses open to all golfers, with the rest considered private golf clubs that require a membership.

 

Management Team

Noah DiPasquale is a co-founder and CEO of GolfLync Inc., leading the marketing and operations of the platform. He is also the founder and CEO of Epic Golf Club, a premier national membership and private golf society which partners with hundreds of top tier private golf clubs allowing Epic members access to their courses and recently founded the Epic Foundation, a Scottsdale-based 501c3. He holds a B.S. in Business Administration, Management and Operations from the W.A. Franke College of Business at Northern Arizona University and an MBA in Marketing from the University of Phoenix.

Michael Quiel is a co-founder of GolfLync Inc. and the President of the organization. He leads the application development and research teams. Michael understands how to build successful companies. His deep knowledge of investment banking, finance and building successful business partnerships is unparalleled. He’s an expert at capital formation and growth hacking companies. He has raised over $250 million in capital and taken multiple companies public.

Recent News

chart

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

Industry experts say China's various mobile payment systems are facilitating higher rates of holiday consumption in the east Asian country. Although mobile money has been around for well over a decade, the technology reached the mainstream within the past couple of years. The coronavirus pandemic was instrumental in increasing the global popularity of these services because it discouraged handling physical cash. China was quick to jump onto the bandwagon and now has some of the most dominant mobile-payment platforms in the world. The majority of these payment options have also been availed to foreigners, allowing them to link up their local mobile wallets with Chinese services such as Alipay for more seamless financial transactions. Industry experts note that these payment options contributed to a new wave of tourist-related consumption during the recently concluded National Day holiday. Chinese authorities have also noticed the benefits of adopting mobile money and are also keen on making the services more accessible to businesses. The State Administration for Market Regulation and the National Data Administration recently announced a pilot program that would help business owners in eight cities adopt mobile money to stimulate further mobile money use by foreigners. This surge in the use of mobile-payment platforms offers enterprises such as FingerMotion Inc. (NASDAQ: FNGR) an opportunity to deepen their penetration of the market.

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Tuesday's trading session at $2.135, off by 2.2883%, on 156,288 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.63/$7.25.

Recent News

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Chronic labor shortages in the hospitality sector force operators to adopt automated solutions

Nightfood subsidiary offers key robotics and automation solutions designed to revolutionize both front-end and back-end operations within the hospitality industry

Recent research released by the U.S. Chamber of Commerce indicated that the leisure/hospitality industry has been hit hardest by the country's perpetual labor shortage. This shouldn't surprise anyone who has eaten or traveled in recent years. The short staffing is hard to miss, as it's crippling the guest experience and guest satisfaction ratings. Nightfood Holdings (OTCQB: NGTF) through its recently acquired subsidiary, Future Hospitality Ventures Holdings Inc., is solving this industry-wide problem with plug-and-play robotics and solutions which enhance service efficiency and consistency (https://ibn.fm/rSIBn).

Nightfood Holdings Inc. (OTCQB: NGTF) is a visionary holding company focused on identifying and capitalizing on explosive market trends within hospitality, food services and consumer packaged goods. By leading newly emerging categories and seizing opportunities in markets undergoing transformational upheaval, the company’s mission is to create unparalleled upside potential in industries ripe for innovation and growth.

Subsidiaries

Nightfood Inc.

The company’s flagship subsidiary, Nightfood Inc., is changing the way the world snacks at night. Humans are biologically hard-wired to crave sweets and fats at night – a survival mechanism from our hunter-gatherer days. Modern consumers know bingeing excess calories before the long nightly fast is no longer necessary for survival, but exploding screen time and decreased willpower at night results in over 90% of American adults snacking between dinner and bed every week, contributing to an estimated one billion nighttime snack occasions weekly (according to SleepFoundation.org).

The most popular choices – ice cream, cookies, chips and candy – are not only unhealthy but also impair sleep quality due to their nutritional profiles. Nightfood snacks are uniquely formulated by sleep and nutrition experts to satisfy nighttime cravings AND support better sleep.

Market Opportunity

Euromonitor International projects the American snack market will grow from $150 billion in 2022 to $170 billion in 2027. Snacking between dinner and bed is estimated to account for over $60 billion annually, creating an opportunity for a multi-billion-dollar sub-category to emerge in the coming years: sleep-friendly snacking.

Nightfood is the brand pioneering that category.

Nightfood’s innovation has led to partnership overtures from global giants, including the largest food and beverage company in the world, Nestlé, with whom Nightfood completed a “test-and-learn” joint initiative in 2023.

Management believes that successfully scaling Nightfood’s 2024 direct-to-consumer launch of sleep-friendly cookies will bring the category to life, opening the door for partnerships with and potential acquisition by global snack giants seeking to lead this potential billion-dollar emerging sub-category.

Future Hospitality Ventures Holdings Inc. (d/b/a roboOp365)

Future Hospitality Ventures Holdings, operating under the brand roboOp365, is revolutionizing the hospitality industry with cutting-edge automation and robotic solutions.

roboOp365 enhances operational efficiency and guest experiences through innovative technologies, including automated culinary bot, server robots and AI-enhanced applications. roboOp365 helps hospitality providers reduce costs, streamline operations and deliver superior service by integrating these advancements.

Market Opportunity

The robots-as-a-service (RaaS) business model has gained significant traction, super-charged by the COVID-19 pandemic, which instantly catalyzed game-changing growth and application. According to Verified Market Research, the service robotics market is projected to reach $173.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 21.25%. Compared to Asia, the United States market is in the early stages of adopting these technologies, but acceptance is accelerating aggressively.

Several factors are driving this trend. Key industries such as hotels and restaurants are still struggling to rebound from the pandemic’s impact, hoping to return to pre-pandemic levels, if possible. Such recovery will largely be dependent upon service robots. In California specifically, factors such as rising labor costs, more rigorous labor laws and ongoing high turnover rates in labor-intensive sectors make it impossible for businesses to survive, thrive and compete without robotics.

Innovation Across Sectors

Nightfood Holdings Inc. is dedicated to driving innovation across its focus sectors of food services, automation and hospitality applications. In food services, the company leverages automation technology to drive operational efficiency for operators while meeting evolving consumer needs. In the hospitality industry, it’s deploying solutions that redefine guest experiences. Nightfood’s consumer-packaged goods initiatives are key to breakthrough trends in health and wellness.

Synergizing Food and Technology

The synergy of food and technology within Nightfood Holdings Inc. creates a holistic approach to innovation and automation. By integrating these areas, the company offers comprehensive solutions that address multiple facets of market needs. Its automation and artificial intelligence solutions in food service and hospitality create a seamless and enhanced consumer experience.

Through this integrated approach, Nightfood Holdings Inc. not only meets current market demands but also anticipates and influences future trends, positioning itself as a leader in innovation across these interconnected sectors. Synergies in these related and explosive categories result in operational efficiency and benefits for the company’s customers and partners and outsized upside and opportunity for its investors.

Management Team

Sean Folkson is the Chairman and President of Nightfood. He founded Nightfood when he couldn’t find a solution to his nighttime snacking problem. Recognizing the growing body of research linking nutritional intake with sleep quality, he launched the first snack brand specifically formulated to give consumers better, healthier and more sleep-friendly snacks for that peak-cravings slot between dinner and bed. He is a serial entrepreneur and problem-solver, having previously founded Specialty Equipment Direct, an online distributor of floor removal equipment, and AffiliatePros.com, a pioneering company in online affiliate marketing.

Lei Sonny Wang is the CEO of Nightfood Holdings. He is a strategist and business driver for early-stage and growth-stage companies. He is the founder and former CEO of Future Hospitality Ventures Holdings Inc., which was acquired by Nightfood Holdings Inc. At Future Hospitality, he leveraged his significant international business development experience into distribution relationships with leading global robotics manufacturers. At Nightfood, he is working to grow revenue and improve performance and profitability across all subsidiaries.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Tuesday's trading session at $0.0121, off by 0.8196721%, on 204,760 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0075/$0.035.

Recent News

Energy and Water Development Corp. (OTCQB: EAWD)

The QualityStocks Daily Newsletter would like to spotlightFathom Energy and Water Development Corp. (OTCQB: EAWD) .

Energy and Water Development Corp. (OTCQB: EAWD) is a green-tech engineering solutions company focused on delivering water and energy to extreme environments. The company builds water and energy systems out of already existing, proven technologies, utilizing its patent-pending systems configuration and technical know-how to customize solutions to meet clients’ needs. To date, two water systems have been sold and deployed in Mexico and Germany, and the company is working to fulfill additional orders.

Using its patent-pending design, EAWD is working to build and operate off-grid EV charging stations in Germany. The company is a United Nations-accredited vendor and offers design, construction, maintenance and specialty consulting services to private companies, government entities and non-government organizations for the sustainable supply of energy and water.

EAWD focuses on three main aspects of the water and energy business: (1) generation, (2) supply and (3) maintenance. The green tech industry is constantly evolving due to ongoing and increasing water scarcity, as well as increased energy needs in the world. Therefore, the company believes that by designing sustainable and renewable solutions to these problems, EAWD will become an essential component of a rapidly growing industry with many new markets.

EAWD’s approach seeks to assist businesses with the growth and development of their general operations by ensuring the efficient, profitable and sustainable supply and generation of water and energy, allowing its potential customers to focus on their business while adopting strategies of sustainability.

By using the state-of-the-art technological solutions and technologies identified, designed and provided by EAWD and its collaborators, the company believes that its potential clients will be free to focus on the performance of their operations, as well as with the water and energy consumption or generation regulations within their industries.

EAWD is headquartered in Saint Petersburg, Florida, with operations in Germany and Mexico.

Products

In view of the increased worldwide demand for water and energy, EAWD’s business goals are focused on self-sufficient energy-supplied water generation and green energy production. To accomplish this, the company set out to establish an outsourcing green tech platform to commercialize its state-of-the-art technologies while providing engineering and technical consultation services to design the most sustainable technological solutions that can provide water and energy.

The company has sought potential collaboration with green tech research and development centers in Europe and has established its operating subsidiaries in Hamburg, Germany, where EAWD has started to assemble its patent-pending innovative off-grid, self-sufficient energy supply atmosphere water generation (AWG) systems.

EAWD Deutschland and EAWD Logistik operate in Hamburg, Germany, to meet the increasing demands of water and energy generation projects around the world, as well as to operate the solar-powered EAWD Off-Grid EV Charging Stations, EAWD’s newest product.

The company expects to offer sustainable added value to each project it takes on, while generating revenue from the sale of EAWD Off-Grid AWG Systems, EAWD Off-Grid EV Charging Stations, EAWD Off-Grid Power Systems and EAWD Off-Grid Water Purification Systems; royalties from the commercialization of energy and water in certain cases; and licensing of its innovated technologies, along with its engineering, technical consulting and project management services.

EAWD continues to be a development stage company. It presently assembles its EAWD Off-Grid AWG Systems and EAWD Off-Grid EV Charging Stations at its workshop in Germany and outsources most of its engineering and technical services, as well as services relating to the promotion, sale and distribution of its products.

Market Opportunity

According to a report by Allied Market Research, a global market research, consulting and advisory firm, the worldwide green technology and sustainability market was valued at $10.32 billion in 2020 and is projected to reach a value of $74.64 billion by 2030, growing at a CAGR of 21.9% during the forecast period.

A surge in environmental awareness and increasing concerns among organizations and individuals about climate change drive the growth of the market. Furthermore, an increase in consumer and industrial interest for the use of clean energy resources are among some of the major factors expected to boost growth of the market in the coming years, according to the report.

The expected rise in favorable government and private initiatives to tackle climate change and air pollution represent an opportunistic factor of the market. An increase in energy consumption and rise in greenhouse gas emissions are major factors that drive the development of green technology innovations, the report states.

Management Team

Irma Velazquez is CEO and Vice Chair at EAWD. She brings certified expertise in sustainable development and large-scale project management to the company. She formerly worked for United Nations agencies including the World Health Organization, Farmaciens Sans Frontieres, Red Cross and Crescent Societies, where she served in the positions of Information Technology Manager, Sustainable Development Manager, Programme Manager and Disaster and Crisis Management Coordinator. She has a master’s in sciences from the Erasmus University of Rotterdam. She speaks French, English and Spanish.

Ralph Hofmeier is Chief Technology Officer and Chairman at EAWD. He brings a mechanical engineering background to the company and previously served as President of Powermax Energy & Business Solutions Inc. When that company merged with EAWD, he served as President and CEO of Directors of EAWD. Over the last 20 years, he has established and developed several multinational companies in green tech distribution and commercialization. He speaks German and English.

Energy and Water Development Corp. (OTCQB: EAWD), closed Tuesday's trading session at $0.00435, up 27.9412%, on 3,338,603 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.00305/$0.12.

Recent News

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF)

The QualityStocks Daily Newsletter would like to spotlight Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF).

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF), along with its consolidated subsidiaries, is a Canadian oil and gas exploration and production company with operations primarily focused in the Republic of Türkiye.

Headquartered in Canada, the company owns 49% of the SASB natural gas field, which is producing critical domestic supply of natural gas during Europe’s ongoing energy shortages. It also holds a 19.6% (except three wells with 9.8%) ownership interest in the Cendere Oil Field and has a farm-in agreement to earn 50% interest in three oil exploration blocks in southeast Türkiye called Cudi-Gabar.

Trillion Energy utilizes state-of-the-art technology and ingenious practices to produce and distribute oil and natural gas while still maintaining a commitment to sustainable and responsible operations. Whether through the development of new projects or optimizing existing assets, the company continues to seek new and innovative ways to drive growth and value for its stakeholders.

Headquartered in Vancouver, British Columbia, Trillion Energy is led by seasoned professionals who collectively boast over a century of energy exploration and development experience.

Projects

SASB Gas Field

The SASB Gas Field is producing and delivering critical domestic supplies of natural gas as energy shortages grip Europe due to Russia’s invasion of Ukraine.

Located in the southwestern Black Sea, the SASB gas field consists of numerous conventional natural gas pools located in shallow water. The fields have produced over 43 billion cubic feet (BCF) since initial development in 2007 and continue to provide much needed energy to Türkiye and the EU. Total infrastructure to date, including production platforms, pipelines, initial wells and gas processing plant, cost in excess of $600 million.

Trillion Energy is redeveloping the field with a strategic planned program of approximately 17 wells which commenced in 2022. Phase B of the program, targeted for 2024/25, consists of the re-entry of five legacy wells to drill sidetrack development wells and one exploration stratigraphic well.

Cendere Oil Field

Trillion Energy’s Cendere oil field is a long-term, low decline, stable oil production field located in Türkiye. The company has a 19.6% interest in the field, except for three wells in which its interest is 9.8%.

Cash flow after operating costs from the field is $120,000 to $140,000 per month, with average current production netting the company 110-120 barrels of oil per day. Estimated remaining Cendere oil reserves total 1.5 million barrels (0.277 million barrels net Trillion Energy).

The gross value of Trillion Energy’s interest is estimated at $13.85 million (NPV10).

Cudi-Gabar

Trillion Energy’s 10-well oil exploration drilling program is occurring on three prospective oil blocks located in the prolific Cudi-Gabar oil province in southeast Türkiye. The total area of the three blocks is 374,325 acres.

Trillion Energy’s potential 50% working and revenue interest in the blocks is earned by paying 100% of the work program costs. The company will operate the exploration program.
During 2023/24, Trillion Energy will shoot 351 kilometers of 2D seismic (150 km already shot on the eastern block) and drill four wells. The remaining six wells will be paid 50% by Trillion and 50% by the company’s partner. The oil blocks are surrounded by more than 10 major oil discoveries, half of which are recent.

Market Opportunity

A January 2024 report by Emergen Research, a market research and consulting company, estimated the global natural gas market at $310.5 trillion in 2022 and projected the market will be worth $443.8 trillion by 2032, achieving a CAGR of 3.7% during the forecast period. Increasing global economic activity and rising electricity consumption are key factors driving revenue growth of the market, according to the report.

Trillion Energy reports strong demand for natural gas in Türkiye, which is the seventh-largest natural gas consuming country in the world. Türkiye currently imports 98% of the natural gas it consumes, with about 60% of those imports coming from Iran and Russia.

Management Team

Dr. Arthur Halleran is CEO and Director of Trillion Energy. He has a Ph.D. in Geology from the University of Calgary and 44 years of petroleum exploration and development experience. His international experience includes work in Canada, Colombia, Egypt, India, Guinea, Sierra Leone, Sudan, Suriname, Chile, Brazil, Bulgaria, Türkiye, Pakistan, Peru, Tunisia, Trinidad Tobago, Argentina, Ecuador and Guyana. Dr. Halleran has worked for Petro-Canada, Chevron, Rally Energy and United Hydrocarbon International Corp. In 2007, he founded Canacol Energy Ltd., now the largest natural gas producer in Colombia.

Al Thorsen is COO of Trillion Energy. He is responsible for production operations of the SASB gas field, as well as future drilling activities in Türkiye and abroad. Highlights of his career include Valeura Energy Inc. as operations manager in Türkiye; Journey Energy, leading a production team; Rio Alto Exploration as country manager and production manager; Zargon Oil and Gas as VP of Operations; Orleans Energy as VP of Operations; and Central Petroleum as COO. He holds a Bachelor of Science in Petroleum Engineering from Montana College of Mineral Science & Technology.

Trillion Energy International Inc. (OTCQB: TRLEF), closed Tuesday's trading session at $0.0757, up 5.5788%, on 24,500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0609/$0.5655.

Recent News

Bebuzee Inc. (OTC: BBUZ)

The QualityStocks Daily Newsletter would like to spotlightFathom Bebuzee Inc. (OTC: BBUZ) .

Bebuzee Inc. (OTC: BBUZ), formerly Engage Mobility Inc., is a social platform and streaming service focused on development and deployment of America’s first superapp. The superapp will allow members to watch a wide variety of content, such as movies, series, documentaries and talk shows, on any internet-connected device.

Bebuzee’s technology scans the world’s news, features and information-flow to give its dedicated readers the best of the internet in one place – a one-stop platform for breaking news, interesting and important blogs, videos and photos.

The core features of the superapp include video streaming; photo sharing; Bebuzee Messaging service, which allows users to send text and voice messages and make voice and video calls; Shortbuz, used to make a variety of short-form entertaining videos; Blogbuz, a resource for people without time to scavenge the internet and other sources for news and information; Properbuz global real estate search; global tradesmen search; location reviews of neighborhoods, cities and even regions to help others find their ideal rental or real estate purchase; ShoppingBuz, a unique technology-driven e-commerce platform which gives merchants incredible tools to sell their products; Bebuzee Pay, a mobile payment and digital wallet service that allows users to make mobile payments and online transactions; TravelBuz, an online travel booking service; EventBuz, a ticket exchange and resale platform; and FlightBuz, a flight search engine.

The company is headquartered in Miami.

Introducing the Superapp to Western Markets

A superapp is a mobile phone app that offers a wide range of services within a single platform. This technology allows users to access various services without downloading and switching between multiple apps.

While superapps are popular in many parts of the world, including Latin America, Africa, the Middle East, Asia and Russia, they have achieved little adoption in Western markets. Perhaps the most widely known superapp is WeChat, which is estimated to have as many as 1.24 billion users, mostly in China.

Bebuzee aims to be the first developer to introduce and grow to widespread popularity a superapp in the U.S. and Europe. It took a strong step toward achieving this goal during the COVID-19 pandemic, when Bebuzee’s user base surged by 78% with over 42 million new users.

Whereas most social platforms are generic and only local postings make them somewhat relevant to local communities, Bebuzee has localized its platform for most countries by providing local content, entertainment and information that is frequently updated and refreshed.

The company says the average age of its superapp users is 39, with female users making up 62.8% of its user base. Its monetization strategy includes sales of video advertising, sponsored posts, banner ads and premium listings, as well as promotion of featured brands and property listings.

Market Opportunity

A report from Allied Market Research, a global market research, consulting and advisory firm, estimated that the worldwide superapps market was valued at $58.6 billion in 2022. The report projects the market to expand to $722.4 billion by 2032, growing at a CAGR of 28.9% for the forecast period.

The report identifies a few of the most popular superapps as Rappi in Latin America, Snapp in Iran, Line in Japan and Yandex Go in Russia and Kazakhstan.

Increasing adoption of mobile services and growing advancements in digital technologies are driving the growth of this market. In addition, a rise in government support for promoting the use of superapps is lending to expansion, according to the report.

Integration of blockchain technology in superapps is likewise anticipated to provide numerous opportunities for the expansion of the market during the forecast period, the report states.

Management Team

Joseph Onyero is Founder and CEO of Bebuzee. He has a background of managing multiple products from ideation to market launch and profitable monetization and has been building commercial web presences since 2005. He has worked as a Chief Marketing Officer and in business development. He previously owned and operated a travel and tourism company. He began in 2005 working on the concept and features that have evolved into the Bebuzee suite. He has grown Bebuzee from a living room start-up into a U.S. publicly traded company.

Claudia S. Spagnuolo is Chief Operating Officer at Bebuzee. She began with the company in 2014 as a user experience manager before being promoted to CMO in 2017. She previously worked as an assistant marketing director at the National Secretariat of the union CISL in Italy. Prior to that, she also worked as a researcher at the Complutense University of Madrid on issues of corporate management. She speaks three languages and holds a bachelor’s in political science and a master’s in administration from the University of Perugia in Italy.

Bebuzee Inc. (OTC: BBUZ), closed Tuesday's trading session at $0.05, up 31.5789%, on 62,750 volume. The average volume for the last 3 months is 40,162 and the stock's 52-week low/high is $0.01955/$0.359.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Tuesday's trading session at $0.0791, even for the day. The average volume for the last 3 months is 28,711 and the stock's 52-week low/high is $0.0364/$0.1164.

Recent News

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Tuesday's trading session at $7.55, up 11.1929%, on 71,101 volume. The average volume for the last 3 months is 311,746 and the stock's 52-week low/high is $3.70/$110.00.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.